A
Anderson, David C.
Argoff, C. E.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
B
Bartolomei, F.
- Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyF. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis
Becker, J. T.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
Benito-León, Julián
- Population-based prospective study of cigarette smoking and risk of incident essential tremorElan D. Louis, Julián Benito-León, Félix Bermejo-Pareja
Bermejo-Pareja, Félix
- Population-based prospective study of cigarette smoking and risk of incident essential tremorElan D. Louis, Julián Benito-León, Félix Bermejo-Pareja
Bezzi, G.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
Blitzer, A.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
Brashear, A.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
C
Cerri, F.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
Chang, Y. F.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
Chauvel, P.
- Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyF. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis
Childers, M. K.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Cho, Tracey A.
- Education Research: A program perspective on learning how to teachKevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho
Clemons, T.
- Applicability of NINDS-sponsored studies to community-based physician involvementA. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart
Comella, C.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
Comi, G.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
D
Dalton, A.
- HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIERC.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw
DeKosky, S. T.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
Dubinsky, R.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
Dykstra, D. D.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
E
Epis, R.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
F
Felson, David T.
- Protective effects of NSAIDs on the development of Alzheimer diseaseSteven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson
Fischer, C.
- Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyF. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis
G
Gach, H. M.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
Gracies, J-M
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
Graham, H. K.
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
Grew, S.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
Gronseth, G. S.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
H
Hallett, M.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
Hart, R. G.
- Applicability of NINDS-sponsored studies to community-based physician involvementA. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart
Hayashi, M.
- Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyF. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis
Hewamadduma, C.A.A.
- HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIERC.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw
J
Jabbari, B.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Jankovic, J.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
Johnson, Lorraine
K
Karp, B.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
Kaufmann, H. C.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Kershaw, C.
- HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIERC.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw
Kirby, J.
- HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIERC.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw
Kowall, Neil W.
- Protective effects of NSAIDs on the development of Alzheimer diseaseSteven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson
Kuller, L. H.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
L
Lindblad, A. S.
- Applicability of NINDS-sponsored studies to community-based physician involvementA. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart
Lindblad, R. W.
- Applicability of NINDS-sponsored studies to community-based physician involvementA. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart
Lopez, O. L.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
Louis, Elan D.
- Population-based prospective study of cigarette smoking and risk of incident essential tremorElan D. Louis, Julián Benito-León, Félix Bermejo-Pareja
Ludlow, C. L.
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
M
Magdelaine, C.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
Martindale, J.
- HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIERC.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw
Mascitelli, Luca
- STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE: A CONTROLLED RANDOMIZED STUDYLuca Mascitelli, Francesca Pezzetta
McDermott, C. J.
- HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIERC.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw
Meador, K. J.
- Applicability of NINDS-sponsored studies to community-based physician involvementA. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart
Mehta, P. D.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
Meyer, Tanya
- Teaching Video NeuroImage: Spasmodic dysphoniaAdductor and abductorStephen G. Reich, Tanya Meyer
Miller, Donald R.
- Protective effects of NSAIDs on the development of Alzheimer diseaseSteven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson
Miyasaki, J. M.
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
N
Naumann, M.
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Nemni, R.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
Nicholson, G. A.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
O
Odenkirchen, J. C.
- Applicability of NINDS-sponsored studies to community-based physician involvementA. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart
Ouvrier, R. A.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
P
Pezzetta, Francesca
- STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE: A CONTROLLED RANDOMIZED STUDYLuca Mascitelli, Francesca Pezzetta
Ponzoni, M.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
Previtali, S. C.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
Q
Quattrini, A.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
R
Régis, J.
- Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyF. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis
Reich, Stephen G.
- Teaching Video NeuroImage: Spasmodic dysphoniaAdductor and abductorStephen G. Reich, Tanya Meyer
Rey, M.
- Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyF. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis
Riva, N.
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASEN. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini
Russman, B.
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
Ryan, M. M.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
S
Schurch, B.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Shaw, P. J.
- HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIERC.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw
Sheth, Kevin N.
- Education Research: A program perspective on learning how to teachKevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho
Silberstein, S. D.
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Simpson, D. M.
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Simpson, L. L.
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
So, Y.
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson
Spencer, Susan S.
Stricker, Raphael B.
Sturtz, F.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
Sweet, R. A.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
Sykes, R.
- Applicability of NINDS-sponsored studies to community-based physician involvementA. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart
T
Tamura, M.
- Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyF. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis
Tracy, R.
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyO. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky
V
Vallat, J. -M.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
Vlad, Steven C.
- Protective effects of NSAIDs on the development of Alzheimer diseaseSteven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson
Vossel, Keith A.
- Education Research: A program perspective on learning how to teachKevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho
W
Wijdicks, Eelco F.M.
- Plantar flexion and flexion synergy in brain deathAlexander Y. Zubkov, Eelco F.M. Wijdicks
Y
Yu, Timothy W.
- Education Research: A program perspective on learning how to teachKevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho
Z
Zhu, D.
- Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutationsG. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier
Zubkov, Alexander Y.
- Plantar flexion and flexion synergy in brain deathAlexander Y. Zubkov, Eelco F.M. Wijdicks
Advertisement
Popular on
Neurology

Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Advertisement